Amgen's Repatha Pricing Deal With Harvard Pilgrim Hinges On Results, Utilization

Additional discounts kick in if patients don't achieve same LDL cholesterol reduction seen in clinical trials and if utilization is excessive.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America